Treatment-resistant Depression
📧 Sign up to get email alerts when something new happens for Treatment-resistant Depression.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-06-26Clinical Trial Update: Action of Ketamine in Treatment-Resistant Depression [Phase 2, Phase 3]
The document summarizes the completion status of Phase 2 and Phase 3 trials evaluating ketamine for treatment-resistant depression.
-
CLINICAL_TRIALS trial_result · 2018-06-11Clinical Trial Update: Nuedexta in Treatment-Resistant Major Depression [Phase 2]
Phase 2 trial evaluating Nuedexta (dextromethorphan/quinidine) for treatment-resistant major depressive disorder. Results were posted in Jun…
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression (TRD) [Phase 2]
Phase 2 double-blind, placebo-controlled trial evaluating ketamine therapy for treatment-resistant depression; results were posted in 2018.
-
CLINICAL_TRIALS trial_result · 2017-12-08Clinical Trial Update: Implementation Trial of Evidence Based Practices for Mood Disorders [NA]
Completion of an implementation trial evaluating evidence-based practices for mood disorders, including bipolar disorder and treatment-resis…
-
CLINICAL_TRIALS trial_result · 2017-09-13Clinical Trial Update: Comparing Ketamine and Propofol Anesthesia for Electroconvulsive Therapy [Phase 4]
A Phase 4 clinical trial compared ketamine versus propofol anesthesia for electroconvulsive therapy in treatment-resistant depression; the s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-08-24Clinical Trial Update: A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression [Phase 3]
Phase 3 trial investigating olanzapine and fluoxetine for treatment-resistant depression has been terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Proof-of-Concept Trial of CERC-501 Augmentation of Antidepressant Therapy in Treatment-Resistant Depression [Phase 2]
Phase 2 proof-of-concept trial evaluating augmentation of antidepressant therapy with CERC-501 in treatment-resistant depression was termina…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Trial of Low Field Magnetic Stimulation Augmentation of Antidepressant Therapy in Treatment-Resistant Depression [NA]
A completed clinical trial evaluating low field magnetic stimulation as an augmentation to antidepressant therapy for treatment-resistant de…
-
CLINICAL_TRIALS trial_result · 2016-09-05Clinical Trial Update: Minocycline as an Adjunct for the Treatment of Depressive Symptoms: Pilot Randomized Controlled Trial [Phase 4]
This completed Phase 4 pilot randomized trial evaluated minocycline as an adjunct therapy for depressive symptoms.
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: D-cycloserine for Relapse Prevention Following Intravenous Ketamine in Treatment-resistant Depression [Phase 4]
A Phase 4 clinical trial update evaluating D-cycloserine for relapse prevention after intravenous ketamine treatment in treatment-resistant …
-
CLINICAL_TRIALS trial_result · 2016-05-02Clinical Trial Update: An Open Label Study of Clinical Utility and Patient Outcomes of the Genecept Assay [NA]
Open-label study evaluating the clinical utility and patient outcomes of the Genecept Assay in treatment-resistant depression and generalize…
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: Cognitive and Drug Therapy for Drug-Resistant Depression [NA]
A completed clinical trial evaluating cognitive and pharmacologic therapies for treatment-resistant depression.
-
CLINICAL_TRIALS trial_result · 2015-08-26Clinical Trial Update: Pulsating ElectroMagnetive Treatment (PEMF) at Treatment Resistant Depression [Phase 3]
Phase 3 clinical trial evaluating Pulsating Electromagnetic Treatment (PEMF) for treatment-resistant depression has completed, sponsored by …
-
CLINICAL_TRIALS trial_result · 2015-03-17Clinical Trial Update: Ketamine for Treatment-resistant Depression: A Multicentric Clinical Trial in Mexican Population [Phase 2]
This document reports a Phase 2 multicenter clinical trial evaluating ketamine for treatment-resistant depression in a Mexican population. T…
-
CLINICAL_TRIALS trial_result · 2014-03-06Clinical Trial Update: Exercise in Treatment Resistant Depression (TRD): A Feasibility Study [NA]
A completed feasibility trial investigating exercise as a treatment option for treatment-resistant depression.
-
CLINICAL_TRIALS trial_result · 2014-01-31Clinical Trial Update: Optimization of IV Ketamine for Treatment Resistant Depression [Phase 2]
Phase 2 trial assessing optimized IV ketamine dosing for treatment-resistant depression (and major depressive disorder); results were posted…
-
CLINICAL_TRIALS trial_result · 2013-02-25Clinical Trial Update: Study Comparing Outcomes for Patients With Treatment Resistant Depression Who Receive VNS Therapy at Different Doses [Phase 4]
A Phase 4 study reports results comparing outcomes for treatment-resistant depression patients treated with VNS therapy at different dose le…
-
CLINICAL_TRIALS trial_result · 2012-07-10Clinical Trial Update: Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression [Phase 2]
Phase 2 trial results update describing the efficacy, safety and tolerability of CX157 in treatment-resistant depression.
-
CLINICAL_TRIALS trial_result · 2012-05-23Clinical Trial Update: Comparing Quetiapine XR Monotherapy and Augmentation With Lithium Augmentation in TRD Patients [Phase 3]
Phase 3 clinical trial comparing quetiapine XR as monotherapy versus augmentation with lithium in treatment-resistant depression. Results we…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: An Investigation of the Antidepressant Efficacy of the 5-HT2A Antagonist, M100907, in Combination With Citalopram in Treatment Resistant Depression [Phase 2]
A Phase 2 trial evaluating whether adding the 5-HT2A antagonist M100907 to citalopram improves outcomes in treatment-resistant depression; t…